US$ 20.22
peptídeos klow BLEND KLOW Blend Vial 80mg |
Description
SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1alpha pathway and Drp1-mediated mitochondrial fission in ovarian cancer

doi:10.1016/j.ejps.2009.02.019

and K99-DC021195 to C.N.M.), National Science Foundation (NeuroNex UTA20-000889 to A.Y.T

Most expensive option and requires clinic visits

Don't forget astrocytes when targeting Alzheimer's disease

The supportive research is overwhelmingly preclinical rat and cell-culture studies of the individual peptides, not randomized human trials of the blend
